Ibrance 75 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26FS8KE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,561
Award facts
- Contract value 100% obligated
- $8,561.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,561.41 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Ibrance 75 mg capsules (21-count units). This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by December 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive range of medications, vaccines, medical devices, and healthcare commodities to support military and veteran healthcare systems. As a prime contractor under the DLA's pharmaceutical supply framework, the company fulfills delivery orders across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard. This particular order for Ibrance, an oncology medication, represents a routine fulfillment of medical supply needs within the company's broader role as a primary pharmaceutical supplier to the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FS8KE?
SPE2DR26FS8KE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FS8KE worth?
The government has obligated $8,561 on SPE2DR26FS8KE.
Is contract SPE2DR26FS8KE an order under another contract?
Yes. SPE2DR26FS8KE is a delivery order under SPE2DR25D3021, an indefinite delivery contract.
Was contract SPE2DR26FS8KE competed?
The extent of competition for SPE2DR26FS8KE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award